Category: BA.1.1
Multiple hypermutated SARS-CoV-2 sequences that may have been created by molnupiravir
Molnupiravir, a drug used to treat SARS-CoV-2 infections, has received a lot of press attention since its launch, and not all of it has been positive. More...
China: 50 SARS-CoV-2 sequences uploaded to Gisaid
Gisaid have published a report recently on fifty SARS-CoV-2 genome sequences uploaded by China which seems to have gone largely unnoticed by the mainstream media. More...
China: new subvariant of BA.1.1 found in Suzhou
China is battling record coronavirus infection numbers as its fight against the Omicron variant intensifies. More...
Netherlands: BA.1.1/BA.2 recombinant designated XM
A recombinant SARS-CoV-2 variant originally sequenced in the Netherlandshas been designated XM. More...
Bill Gates: “Omicron, is a type of vaccine…”
Microsoft co-founder Bill Gates was recently recorded as saying “Sadly, the virus itself, particularly, the variant called omicron, is a type of vaccine, that is, it creates both B-cell and T-cell immunity, and it’s done a better job getting out to the world population than we have with vaccines.” More...
SARS-CoV-2 potential recombinants in Brazil, Belgium, France, Netherlands, US, Finland, Puerto Rico, Spain
SARS_CoV-2 recombinants seem to have been popping up across the globe recently. More...
Denmark Covid-19 Trends Report – Week 12
Denmark’s Covid-19 trends report for Week 12 of 2022 shows BA.2_H78Y is still stable at about 28% of sequences. More...
Preprint: Identification of Deltacron recombinants in the United States
In this report, we describe viruses with recombinant genomes containing signature mutations from Delta and Omicron variants. More...
Denmark Covid-19 Trends Report – Week 10
Denmark’s Covid-19 trends report for Week 10 of 2022 shows BA.2_H78Y is stable at about 27% of sequences for the third week in a row. More...
Denmark: Omicron BA.2.H78Y cases stable in Week 9 infections report
Denmark has published its latest Covid-19 infections report for Week 9 of 2022. More...